AzTrials
AzTrials

Cardiac Arrest, Out-Of-HospitalAID-OMIENCT06767709

AID-OMIE - Artificial Intelligence in Detection of Occlusive Myocardial Infarction in Emergency Medicine

An observational study of Cardiac Arrest, Out-Of-Hospital and Cardiac Arrest Due to Underlying Cardiac Condition, run by Institute of Mountain Emergency Medicine.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

Study Objective and Hypothesis The study hypothesizes that artificial intelligence (AI)-assisted interpretation of the 12-lead electrocardiogram (ECG) can improve the care of patients resuscitated after out-of-hospital cardiac arrest (OHCA) by enabling faster and more accurate detection of occlusion myocardial… Read more about this study

Who is it for?
Ages 18 years and older
How many people
200 participants
Where
No sites listed yet
Study dates
1 Sep 2025to 31 May 2026
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Patients who suffered OHCA from presumed cardiac cause and sustained ROSC.

Who may be able to join

  • OHCA from with ROSC in the Province of Bolzano, Italy
  • Coronary angiography (CAG) within 7 days post-OHCA
  • Age > 18 years
  • Available prehospital post-ROSC ECG
  • Available CAG report

Who cannot join

  • In-Hospital Cardiac Arrest (IHCA)
  • Age < 18 years
  • Traumatic cardiac arrest
  • Cardiac arrest from a clear non-cardiac cause
  • Corrupted ECG images
  • Poor ECG digitalization quality

Trial locations and contacts

No sites are listed yet. Contact the study team or a site near you to ask about taking part.

Simon Rauch, MD, PhD contact

+393404967398

simon.rauch@eurac.edu

About this study

Study Objective and Hypothesis The study hypothesizes that artificial intelligence (AI)-assisted interpretation of the 12-lead electrocardiogram (ECG) can improve the care of patients resuscitated after out-of-hospital cardiac arrest (OHCA) by enabling faster and more accurate detection of occlusion myocardial infarction (OMI). This enhanced diagnostic approach could reduce the time required for revascularization, improve patient outcomes, and decrease unnecessary activations of cardiac catheterization laboratories. The primary objective of the study is to assess the effectiveness of an AI-powered ECG model in identifying acute OMI in OHCA patients whose post-return of spontaneous circulation (ROSC) ECG does not show ST-elevation.

Methods

Read more

This is a retrospective observational study involving OHCA patients in Bolzano, Italy, who meet the following inclusion criteria:

Aged 18 years or older. Achieved ROSC after cardiac arrest. Underwent coronary angiography (CAG) within seven days post-OHCA. Prehospital post-ROSC ECG and CAG reports available.

Exclusion criteria include in-hospital cardiac arrest (IHCA), traumatic cardiac arrest, cardiac arrest from a non-cardiac cause, and poor-quality or corrupted ECG images. Post-ROSC ECGs will be analyzed using the PMcardio App, an AI tool for ECG interpretation. The data will be fully anonymized before storage. Coronary angiography charts will be reviewed for the presence of atherosclerotic lesions, the degree of arterial narrowing, and Thrombolysis in Myocardial Infarction (TIMI) flow, which assesses blood flow in coronary arteries.

Study Outcomes The primary outcome is the sensitivity and specificity of the AI-assisted ECG in detecting OMI in patients whose post-ROSC ECG does not show ST-elevation. Secondary outcomes include the frequency of OMI in OHCA patients without ST-elevation and the ability of the AI model to rule out OMI accurately in these cases.

Read the detailed description

Study Objective and Hypothesis The study hypothesizes that artificial intelligence (AI)-assisted interpretation of the 12-lead electrocardiogram (ECG) can improve the care of patients resuscitated after out-of-hospital cardiac arrest (OHCA) by enabling faster and more accurate detection of occlusion myocardial infarction (OMI). This enhanced diagnostic approach could reduce the time required for revascularization, improve patient outcomes, and decrease unnecessary activations of cardiac catheterization laboratories. The primary objective of the study is to assess the effectiveness of an AI-powered ECG model in identifying acute OMI in OHCA patients whose post-return of spontaneous circulation (ROSC) ECG does not show ST-elevation.

Methods

This is a retrospective observational study involving OHCA patients in Bolzano, Italy, who meet the following inclusion criteria:

OHCA from 2018-2025 Aged 18 years or older. Achieved ROSC after cardiac arrest. Underwent coronary angiography (CAG) within seven days post-OHCA. Prehospital post-ROSC ECG and CAG reports available.

Exclusion criteria include in-hospital cardiac arrest (IHCA), traumatic cardiac arrest, cardiac arrest from a non-cardiac cause, and poor-quality or corrupted ECG images. Post-ROSC ECGs will be analyzed using the PMcardio App, an AI tool for ECG interpretation. The data will be fully anonymized before storage. Coronary angiography charts will be reviewed for the presence of atherosclerotic lesions, the degree of arterial narrowing, and Thrombolysis in Myocardial Infarction (TIMI) flow, which assesses blood flow in coronary arteries.

Study Outcomes The primary outcome is the sensitivity and specificity of the AI-assisted ECG in detecting OMI in patients whose post-ROSC ECG does not show ST-elevation. Secondary outcomes include the frequency of OMI in OHCA patients without ST-elevation and the ability of the AI model to rule out OMI accurately in these cases.

Keywords
Cardiac arrest, OHCA, Occlusion myocardial infarction, OMI, Artificial intelligence
Medical subject headings
Out-of-Hospital Cardiac Arrest, Heart Arrest

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT06767709
Study groupRoleWhat they receive
Patients after Out-of-Hospital Cardiac Arrest (OHCA) with ROSC in the Province of Bolzano, ItalyPatients after Out-of-Hospital Cardiac Arrest (OHCA) with Return of Spontaneous Circulation (ROSC) in the Province of Bolzano, Italy

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Sensitivity and specificity of detecting OMI from the post-ROSC ECG with AI-assisted ECG interpretation in patients following OHCA with ROSC, where the post-ROSC ECG does not show ST-elevation.

    Sensitivity and specificity of detecting occlusion myocardial infarction (OMI) from the electrocardiogram (ECG) taken after return of spontaneous circulation (ROSC) using artificial intelligence (AI)-assisted ECG interpretation in patients resuscitated from out-of-hospital cardiac arrest (OHCA) with ROSC, where the post-ROSC ECG does not display ST-segment elevation.

    Measured: Within 7 days after OHCA

Secondary outcomes (2)
  1. Frequency of OMI post-OHCA without ST-elevation in the post-ROSC ECG

    Frequency of occlusion myocardial infarction (OMI) in patients resuscitated from out-of-hospital cardiac arrest (OHCA) who achieved return of spontaneous circulation (ROSC), where the electrocardiogram (ECG) recorded post-ROSC does not show ST-segment elevation.

    Measured: Within 7 days after OHCA

  2. Sensitivity and specificity of excluding OMI with AI-assisted ECG interpretation in patients following OHCA with ROSC, where the post-ROSC ECG does not show ST-elevation.

    Sensitivity and specificity of ruling out occlusion myocardial infarction (OMI) using artificial intelligence (AI)-assisted electrocardiogram (ECG) interpretation in patients resuscitated from out-of-hospital cardiac arrest (OHCA) who achieved return of spontaneous circulation (ROSC), where the post-ROSC ECG does not display ST-segment elevation.

    Measured: Within 7 days from OHCA

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted10 Jan 2025
  2. Study start1 Sep 2025 (estimated)
  3. Primary completion30 May 2026 (estimated)
  4. Study completion31 May 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case only
Time perspective
Retrospective
Enrolment
200 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06767709
Sponsor's protocol ID
01-2025
Acronym
AID-OMIE
Status last verified
Aug 2025
First submitted
5 Jan 2025
Last updated
8 Aug 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Cardiac Arrest, Out-Of-Hospital and Cardiac Arrest Due to Underlying Cardiac Condition, run by Institute of Mountain Emergency Medicine.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 8 Aug 2025. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Simon Rauch, MD, PhD (+393404967398, simon.rauch@eurac.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Sensitivity and specificity of detecting OMI from the post-ROSC ECG with AI-assisted ECG interpretation in patients following OHCA with ROSC, where the post-ROSC ECG does not show ST-elevation. (time frame: Within 7 days after OHCA). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 Aug 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in